Long-term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease.

Abstract

BACKGROUND Hepatotoxicity results in the withdrawal of thiopurines drugs, azathioprine (AZA) and mercaptopurine (MP), in up to 10% of patients with inflammatory bowel disease. Our group previously demonstrated that allopurinol with AZA/ciclosporin/steroid 'triple therapy' improved renal graft survival. AIM To confirm the hypothesis that allopurinol may… (More)

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Cited By

Sort by:

Low allopurinol doses are sufficient to optimize azathioprine therapy in inflammatory bowel disease patients with inadequate thiopurine metabolite concentrations

Ivanka Curkovic, Katharina M. Rentsch, +4 authors Alexander Jetter
European Journal of Clinical Pharmacology
2013

Allopurinol in combination with thiopurine induces mucosal healing and improves clinical and metabolic outcomes in IBD

Brigitte Moreau, Pierre Clement, Yves Theoret, Ernest G. Seidman
Therapeutic advances in gastroenterology
2017

Azathioprine with Allopurinol: Lower Deoxythioguanosine in DNA and Transcriptome Changes Indicate Mechanistic Differences to Azathioprine Alone

Sally A. Coulthard, Phil Berry, Sarah McGarrity, Simon McLaughlin, Azhar Ansari, Christopher P. F. Redfern
Inflammatory bowel diseases
2017

Combination treatment with 6-mercaptopurine and allopurinol in HepG2 and HEK293 cells #_#x2013; Effects on gene expression levels and thiopurine metabolism

Sofie Haglund, Svante Vikingsson, Sven Almer, Jan Söderman
2017

Compositional Changes in the Gut Mucus Microbiota Precede the Onset of Colitis-Induced Inflammation.

Maria Glymenaki, Gurdeep Singh, +4 authors Sheena M Cruickshank
Inflammatory bowel diseases
2017

Development of a Novel Predictive Model for the Clinical Course of Crohn's Disease: Results from the CONNECT Study.

Yehyun Park, Jae Hee Cheon, +8 authors Won Ho Kim
Inflammatory bowel diseases
2017

Early Life Exposure, Lifestyle, and Comorbidity as Risk Factors for Microscopic Colitis: A Case-Control Study.

Bas P M Verhaegh, Marieke J Pierik, Danny Goudkade, Yvette S M T Cuijpers, Ad A M Masclee, Daisy M A E Jonkers
Inflammatory bowel diseases
2017

Management of Difficult Cases of Autoimmune Hepatitis.

Craig Lammert, Veronica M Loy, Kiyoko Oshima, Samer Gawrieh
Current gastroenterology reports
2016

Pharmacology and Optimization of Thiopurines and Methotrexate in Inflammatory Bowel Disease.

Mehmet Coskun, Casper Steenholdt, Nanne K de Boer, Ole Haagen Nielsen
Clinical pharmacokinetics
2016

Preventive role of chamomile fl owers and fennel seeds extracts against liver injury and oxidative stress induced by an immunosuppressant drug in rats

Fathia A. Mannaa, Nagi A. Ibrahim, Soliman S. Ibrahim, Khaled G. Abdel-Wahhab, Nabila S. Hassan, Saida G. Mohammed
2016

References

Sorry, we couldn't extract any references for this paper.

Slides referencing similar topics

Inflammatory Bowel Disease: Updates in Therapy
Uma Mahadevan • Oct 17, 2017
“Biologic Therapy in Inflammatory Bowel Disease”
Raymond Cross + 2 • Sep 27, 2017
Optimizing Treatment Strategies in the Management of Inflammatory Bowel Disease ( IBD ) Inflammatory Bowel Disease Center
Russell D. Cohen + 1 • Oct 19, 2017
Show More